WGS Q3 2021 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$2B

Q3 2021 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$43M+11.8% YoY

Gross Profit

-$8M-19.2% margin

Operating Income

-$88M-204.4% margin

Net Income

$33M75.8% margin

EPS (Diluted)

$4.93

QoQ Revenue Growth

-8.2%

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$75M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$603M

Total Liabilities

$212M

Stockholders' Equity

$391M

Cash & Equivalents

$461M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$39M	+11.8%
Gross Profit	-$8M	$2M	-499.9%
Operating Income	-$88M	-$56M	-57.6%
Net Income	$33M	-$57M	+157.8%